The experience of MMATISS BioReserch is increasing every year. Up to this date we have acquired wide expertise in different therapeutic areas not only in Mexico, but all over the Latin American region, where a vast number of patients have been recruited in support of an important number of clinical trials.
Our team of Principal Investigators has a strong background and meaningful expertise, for this reason MMATISS BioResearch has achieved to successfully manage a large number of Clinical projects:
Summary of Experience
| Indication & Therapeutic Area | |
|---|---|
| Total Oncology | |
| # Sites | 263 |
| # Patients | 3.027 |
| Phase | II,III & IV |
| # Studies | 29 |
| Countries | Bra,Ar,Chil,Mex,Ecu,Peru,CR,Ven,Col |
| Total Cardiology | |
| # Sites | 491 |
| # Patients | 16,424 |
| Phase | IIa, II , III & IV |
| # Studies | 17 |
| Countries | Bra,Ar,Chi,Mex,Peru,CR,Ven,Ecu, Panama y Guatemala |
| Total Gastroenterology | |
| # Sites | 69 |
| # Patients | 1,478 |
| Phase | IIa , II , III |
| # Studies | 12 |
| Countries | Ar,Ecu,Mex,Gua & CR |
| Total Metabolism | |
| # Sites | 252 |
| # Patients | 4,219 |
| Phase | II , III & IV |
| # Studies | 19 |
| Countries | Br,Ar, Chi,Mex,CR Y Ecu |
| Total Rheumatology | |
| # Sites | 147 |
| # Patients | 6,416 |
| Phase | II , III & IV |
| # Studies | 8 |
| Countries | Mex, Bra, Arg, Ec, Ve & Chi |
| Total Ophtalmology | |
| # Sites | 48 |
| # Patients | 694 |
| Phase | I , II , III |
| # Studies | 8 |
| Countries | Br, Ar, Chi & Mex |
| Total Dermatology and Infectious Diseases | |
| # Sites | 307 |
| # Patients | 6,555 |
| Phase | II , III & IV |
| # Studies | 23 |
| Countries | Br,Ar,Chi, Mex, Cr, Col, Ecu, Gua, Ven, Hon, Nic, Bol El Sal |
| Total Pulmonary | |
| # Sites | 38 |
| # Patients | 576 |
| Phase | II , III |
| # Studies | 3 |
| Countries | Mex & CR |
| Total Pain | |
| # Sites | 13 |
| # Patients | 322 |
| Phase | II , III |
| # Studies | 2 |
| Countries | Mex |
| Total CNS | |
| # Sites | 391 |
| # Patients | 4,719 |
| Phase | IIb , II , III & IV |
| # Studies | 21 |
| Countries | Br, Ar, Chi & Me |
| Total Pilot Trial | |
| # Sites | 18 |
| # Patients | 262 |
| Phase | I , IIa |
| # Studies | 9 |
| Countries | Arg, Br & Mex |
| Total Others | |
| # Sites | 94 |
| # Patients | 1,468 |
| Phase | IIa , II , III , & IV |
| # Studies | 16 |
| Countries | Bra, Ar, Chi, Mex, Peru, CR, Ven Ecu, Panama y Guatemala |
| Gran total | |
| # Sites | 2131 |
| # Patients | 46,160 |
| Phase | |
| # Studies | 167 |
| Countries | Chi |
| Indication & Therapeutic Area | # Sites | # Patients | Phase | # Studies | Countries |
|---|---|---|---|---|---|
| Total Oncology | 263 | 3.027 | II,III & IV | 29 | Bra,Ar,Chil,Mex,Ecu,Peru,CR,Ven,Col |
| Total Cardiology | 491 | 16,424 | IIa, II , III & IV | 17 | Bra,Ar,Chi,Mex,Peru,CR,Ven,Ecu, Panama y Guatemala |
| Total Gastroenterology | 69 | 1,478 | IIa , II , III | 12 | Ar,Ecu,Mex,Gua & CR |
| Total Metabolism | 252 | 4,219 | II , III & IV | 19 | Br,Ar, Chi,Mex,CR Y Ecu |
| Total Rheumatology | 147 | 6,416 | II , III & IV | 8 | Mex, Bra, Arg, Ec, Ve & Chi |
| Total Ophtalmology | 48 | 694 | I , II , III | 8 | Br, Ar, Chi & Mex |
| Total Dermatology and Infectious Diseases | 307 | 6,555 | II , III & IV | 23 | Br,Ar,Chi, Mex, Cr, Col, Ecu, Gua, Ven, Hon, Nic, Bol El Sal |
| Total Pulmonary | 38 | 576 | II , III | 3 | Mex & CR |
| Total Pain | 13 | 322 | II , III | 2 | Mex |
| Total CNS | 391 | 4,719 | IIb , II , III & IV | 21 | Br, Ar, Chi & Me |
| Total Pilot Trial | 18 | 262 | I , IIa | 9 | Arg, Br & Mex |
| Total Others | 94 | 1,468 | IIa , II , III , & IV | 16 | Bra, Ar, Chi, Mex, Peru, CR, Ven Ecu, Panama y Guatemala |
| Gran total | 2131 | 46,160 | 167 | Chi |
